Anti-Il-8 Human Monoclonal Antibody

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

2 Sponsors

7 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 1

Oversight events:

2 serious breaches across 1 trial

View oversight register →

Sponsors using this IMP

Bristol Myers Squibb International Corporation 1 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 1

All trials

2 total

Neoadjuvant immune checkpoint inhibition and novel IO combinations in early-stage colon cancer - the NICHE trial Recruiting

2024-513314-35-00 Phase II 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986253 Given in Combination with Nivolumab or Nivolumab plus Ipilimum… Ended

2023-509061-20-00 Phase I/II 6 countries Bristol Myers Squibb International Corporation

Showing 1–2 of 2 trials

← All drugs A–Z